Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 4Breast Neoplasms 4Brain Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Neoplasms 1Neoplasm, Residual 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Liver Neoplasms 1Leukemia, Hairy Cell 1Leukemia 1Kidney Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma, Hepatocellular 1Cancer Diagnosis 1Burkitt Lymphoma 1Biliary Tract Neoplasms 1Adenocarcinoma 1

Interventions

gallium Ga 68 dotatate 1Tomography, X-Ray Computed 1Radionuclide Imaging 1Positron-Emission Tomography 1Positron Emission Tomography Computed Tomography 1Magnetic Resonance Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Cancer Diagnosis × Magnetic Resonance Imaging × Clear all
NCT03125629 2021-04-09

Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals

Stanford University

Phase 2 Completed
53 enrolled 8 charts

Cancer Diagnosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡